[Cancer of the adrenal cortex treated by O,P"-DDD (author's transl)].
作者信息
Van Geertruyden J, De Myttenaere M, Corvilain J
出版信息
Acta Chir Belg. 1980 Jul-Aug;79(4):299-302.
PMID:7468032
Abstract
Presentation of a case of cancer of the adrenal cortex with hypercorticism, treated by surgery and o,p'-DDD, with temporary clinical and biological remission. The indications and results of chemotherapy with o,p'-DDD are discussed.
摘要
相似文献
1
[Cancer of the adrenal cortex treated by O,P"-DDD (author's transl)].
Acta Chir Belg. 1980 Jul-Aug;79(4):299-302.
2
Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD.
Exp Clin Endocrinol. 1994;102(1):50-3. doi: 10.1055/s-0029-1211265.
3
[Favorable outcome of a recurring malignant adrenocortical tumor under O,P'-DDD therapy].
Ann Pediatr (Paris). 1985 Jun;32(6):541-4.
4
Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.米托坦增强了放疗抑制作用，并在联合治疗中诱导H295R和SW13肾上腺皮质细胞系出现G2期阻滞。
Endocr Relat Cancer. 2008 Jun;15(2):623-34. doi: 10.1677/erc.1.1315.
5
Mitotane effects in a H295R xenograft model of adjuvant treatment of adrenocortical cancer.米托坦在肾上腺皮质癌辅助治疗 H295R 异种移植模型中的作用。
Horm Metab Res. 2010 Sep;42(10):725-30. doi: 10.1055/s-0030-1261923. Epub 2010 Jul 27.
6
7
[Use of mitotane (o,p'-DDD) in adrenal cortex hyperfunction].
Endokrynol Pol. 1982;33(1-3):99-104.
8
Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?评论——低剂量米托坦（邻，对'-滴滴滴）作为肾上腺皮质癌辅助治疗有作用吗？
J Clin Endocrinol Metab. 1999 Apr;84(4):1488-9. doi: 10.1210/jcem.84.4.5625-3.
9
Fine structural and biochemical effects of aminoglutethimide and o,p'-DDD on rat adrenocortical carcinoma 494 and adrenals.
Anat Rec. 1980 Sep;198(1):113-24. doi: 10.1002/ar.1091980109.
10
Adjuvant mitotane therapy of adrenal cancer - use and controversy.肾上腺癌的米托坦辅助治疗——应用与争议
N Engl J Med. 2007 Jun 7;356(23):2415-8. doi: 10.1056/NEJMe078087.
Zotero 插件